DermTech, Inc.

Sümbol: DMTK

NASDAQ

0.6906

USD

Turuhind täna

-0.2126
P/E suhe
0.0002
PEG suhe
23.91M
MRK Cap
0.00%
DIV tootlus

DermTech, Inc. (DMTK) Finantsaruanded

Q: Mis on DermTech, Inc. (DMTK) koguvara?

DermTech, Inc. (DMTK) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete DermTech, Inc. (DMTK) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes DermTech, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016
balance-sheet.row.cash-and-short-term-investments	55.9	126.2	225.3	63.8	15.4	0.4	0	0
balance-sheet.row.short-term-investments	19.1	48.4	48.4	39.5	12.4	146.4	0	0
balance-sheet.row.net-receivables	2.6	4.2	3.8	1.5	0.7	0	0	0
balance-sheet.row.inventory	1	1.8	0.5	0.1	0	0	0	0
balance-sheet.row.other-current-assets	2.3	3.9	3.2	1.5	1.1	0.1	0	0
balance-sheet.row.total-current-assets	61.8	136	232.8	66.9	17.1	0.5	0	0
balance-sheet.row.property-plant-equipment-net	56.7	62.4	12.3	2.7	1	0	0	0
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	3.5	3.5	3	0	0	146.4	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	0	0.2	0.2	0.2	0.1	0	0.2	0.1
balance-sheet.row.total-non-current-assets	60.2	66	15.5	2.9	1.1	146.4	0.2	0.1
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	121.9	202.1	248.3	69.8	18.2	146.9	0.2	0.2
balance-sheet.row.account-payables	1.5	2.4	2.9	1.6	1.6	0	0	0
balance-sheet.row.short-term-debt	3.1	1.8	1.6	0.1	0	0	0	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	51.3	54.1	6.3	0.2	0	0	0	0
Deferred Revenue Non Current	0	0	0	0.6	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	8.7	11.4	6.3	2.8	2.7	0	0.2	0.1
balance-sheet.row.total-non-current-liabilities	51.3	54.1	6.4	0.9	5	5	0	0
balance-sheet.row.other-liabilities	0	0	0	0	-5	0	0	0
balance-sheet.row.capital-lease-obligations	51.3	55.8	7.9	0.3	0	0	0	0
balance-sheet.row.total-liab	64.8	69.7	18.6	6.3	5.7	5.1	0.2	0.1
balance-sheet.row.preferred-stock	0	0	0	69.8	0	0	0	0
balance-sheet.row.common-stock	0	0	0	0	0	141	0	0
balance-sheet.row.retained-earnings	-423.9	-323	-206.4	-126.4	-91.1	0.9	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	0.2	-0.8	-0.1	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	480.9	456.2	436.2	120.1	103.6	0	0	0
balance-sheet.row.total-stockholders-equity	57.2	132.4	229.7	63.5	12.5	141.8	0	0
balance-sheet.row.total-liabilities-and-stockholders-equity	121.9	202.1	248.3	69.8	18.2	146.9	0.2	0.2
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	57.2	132.4	229.7	63.5	12.5	141.8	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-
Total Investments	22.6	48.4	48.4	39.5	12.4	146.4	0	0
balance-sheet.row.total-debt	54.4	55.8	7.9	0.3	0	0	0	0
balance-sheet.row.net-debt	17.7	-21.9	-169	-23.9	-15.4	-0.4	0	0

Rahavoogude aruanne

DermTech, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018
cash-flows.row.net-income	-100.9	-116.7	-78.3	-35.2	-19.7	0.9
cash-flows.row.depreciation-and-amortization	5.8	4.5	2.3	0.5	0.1	0
cash-flows.row.deferred-income-tax	-29.8	0	0	0	-0.6	0
cash-flows.row.stock-based-compensation	18.6	18.9	13.3	5	1.3	0
cash-flows.row.change-in-working-capital	0	-2.6	-1.2	1.1	0.7	-0.1
cash-flows.row.account-receivables	1.6	-0.3	-2.4	-0.8	-0.1	0
cash-flows.row.inventory	0.8	-1.3	-0.4	-0.1	0	0
cash-flows.row.account-payables	-1.8	1.9	4.3	0.8	1.3	0
cash-flows.row.other-working-capital	-0.5	-2.8	-2.8	1.2	-0.6	-0.1
cash-flows.row.other-non-cash-items	29.3	0.6	1.9	0	0.4	-1.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-0.9	-3.3	-2.7	-1.8	-0.2	0
cash-flows.row.acquisitions-net	1	-0.7	-0.1	39.5	0	0
cash-flows.row.purchases-of-investments	-34.4	-31.5	-48.1	-41.7	0	-145.2
cash-flows.row.sales-maturities-of-investments	65.2	30.5	38.3	2.2	0	0
cash-flows.row.other-investing-activites	-1	0.7	0.1	-39.5	0	0
cash-flows.row.net-cash-used-for-investing-activites	29.9	-4.3	-12.5	-41.3	-0.2	-145.2
cash-flows.row.debt-repayment	-0.1	-0.1	-0.2	0	-0.5	0
cash-flows.row.common-stock-issued	6.2	0	158.4	43	19.8	146.5
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0
cash-flows.row.other-financing-activites	0.9	1	72	35.9	9.3	-0.5
cash-flows.row.net-cash-used-provided-by-financing-activities	6.1	0.9	230.3	78.9	28.6	146
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-41	-98.7	155.7	8.9	10.6	0.4
cash-flows.row.cash-at-end-of-period	36.7	81.2	179.9	24.2	15.4	0.4
cash-flows.row.cash-at-beginning-of-period	77.8	179.9	24.2	15.4	4.8	0
cash-flows.row.operating-cash-flow	-77	-95.3	-62.1	-28.7	-17.8	-0.4
cash-flows.row.capital-expenditure	-0.9	-3.3	-2.7	-1.8	-0.2	0
cash-flows.row.free-cash-flow	-77.9	-98.6	-64.8	-30.5	-18	-0.4

Kasumiaruande rida

DermTech, Inc. tulud muutusid võrreldes eelmise perioodiga NaN%. DMTK brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018
income-statement-row.row.total-revenue	15.3	14.5	11.8	5.9	3.4	0	0
income-statement-row.row.cost-of-revenue	15	13.9	10.6	6	3.3	0.3	0
income-statement-row.row.gross-profit	0.3	0.6	1.3	-0.1	0.1	-0.3	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0	0	0	0	-0.4	0.3	0
income-statement-row.row.operating-expenses	104	118.8	78.7	35.2	17.7	0.3	0
income-statement-row.row.cost-and-expenses	119	132.7	89.2	41.2	21	0.3	0
income-statement-row.row.interest-income	2.8	1.3	0.2	0	0	1.2	0
income-statement-row.row.interest-expense	0	1.3	0	0	2.7	-1.2	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	2.9	1.5	-0.9	0	-2.1	0	0
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0	0	0	0	-0.4	0.3	0
income-statement-row.row.total-operating-expenses	2.9	1.5	-0.9	0	-2.1	0	0
income-statement-row.row.interest-expense	0	1.3	0	0	2.7	-1.2	0
income-statement-row.row.depreciation-and-amortization	5.8	-0.1	1.1	0.5	-0.4	0	0
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-103.7	-118.2	-77.4	-35.3	-17.6	-0.3	0
income-statement-row.row.income-before-tax	-100.9	-116.7	-78.3	-35.2	-19.7	0.9	0
income-statement-row.row.income-tax-expense	0	-3	-1.4	-0.5	2.2	-1.2	0
income-statement-row.row.net-income	-100.9	-113.7	-77	-34.7	-21.9	0.9	0